<DOC>
	<DOC>NCT02003001</DOC>
	<brief_summary>The aim of this prospective non-randomized study was to assess the efficacy and safety of endomyocardial botulinum toxin injection in left ventricle for preventing ventricular arrhythmias.</brief_summary>
	<brief_title>Botulinum Toxin Injection to Prevent Ventricular Arrhythmias</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia, Ventricular</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>symptomatic ventricular arrhythmias drugresistance unsuccessful one or more ablation procedure with future unreasonable tries Previous heart surgery and AF ablation procedure Emergency CABG Unstable angina or heart failure Use antiarrhythmic drugs within 5 elimination halflives of the drug (or within 2 months for amiodarone) Requiring concomitant valve surgery Left ventricle ejection fraction &lt;35% Unwillingness to participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>